Originally published: Inato and RealTime eClinical Solutions Partner to Deliver Unparalleled Site Performance and Patient Access Data to Sponsors
Choosing the right trial site just got a lot smarter. RealTime eClinical Solutions and Inato have partnered to unite site performance data with patient access insights, giving sponsors and CROs unparalleled visibility into sites that are both high-performing and enrollment-ready.
By uniting RealTime-Devana’s TrialAlign site performance metrics with Inato‘s trusted patient access insights, this collaboration enables sponsors to make site selections based on proven performance and real enrollment potential.
What This Means for Site Selection
- Smarter site selection: Sponsors gain access to TrialAlign’s comprehensive site performance metrics.
- Expanded reach: 50+ large networks representing over 2,000 RealTime-Devana sites can now join the 5,500+ sites already on Inato.
- AI-enabled recruitment: Sites will benefit from Inato’s AI pre-screening solution. this powerful solution cuts chart review times by up to 90% and allowing them to showcase patient access data during feasibility.
- Confidence in collaboration: By combining unbiased performance data with patient access insights, sponsors can more confidently partner with the right sites. Alternately, sites can highlight their readiness to win more trials.
As Barry Lake, Founder and President of RealTime-Devana, shared:
“Unbiased site performance data plus patient access data is the holy grail in terms of site selection and trial feasibility. Through this partnership with Inato, this holy grail can be delivered to sponsors and CROs.”
You can find the complete press release here.
Frequently Asked Questions
Q: What is TrialAlign?
A: TrialAlign is RealTime’s new site selection, feasibility, and performance analytics platform. Powered by RealTime-Devana, it combines proprietary site performance data from thousands of high-performing sites with hundreds of public trial data sources. The result is a 360° view of site readiness, helping sponsors and CROs make smarter, data-driven site selections.
Q: What is Inato?
A: Inato is an AI-enabled platform that expands access to clinical research by connecting sponsors with a global network of 5,500+ sites. Its patient access insights and AI pre-screening tools help sites quickly identify eligible participants and showcase their recruitment capabilities during feasibility — often cutting chart review times by up to 90%.
Q: Why are RealTime and Inato partnering?
A: By combining TrialAlign’s performance metrics with Inato’s patient access data, this partnership gives sponsors an unprecedented level of confidence in site selection. Sponsors can see not only how a site has performed operationally but also whether it has the patient access needed to deliver today.
Q: How do sponsors and CROs benefit?
A: They can reduce risk and improve timelines by selecting sites that are both proven performers and enrollment-ready. That means smarter start-up, stronger recruitment, and cleaner data.
Q: How do sites benefit?
A: Sites gain visibility to top sponsors, can demonstrate their strengths with unbiased performance data and patient access insights, and receive access to AI pre-screening tools to reduce administrative burden and improve trial readiness.